Two Sigma Investments’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-575,111
| Closed | -$11.6M | – | 5118 |
|
|
2021
Q3 | $11.6M | Buy |
575,111
+294,355
| +105% | +$8.13M | 0.03% | 704 |
|
|
2021
Q2 | $10.5M | Buy |
+280,756
| New | +$8.61M | 0.02% | 776 |
|
|
2021
Q1 | – | Sell |
-14,091
| Closed | -$310K | – | 4384 |
|
|
2020
Q4 | $310K | Sell |
14,091
-122,908
| -90% | -$2.71M | ﹤0.01% | 2843 |
|
|
2020
Q3 | $2.46M | Sell |
136,999
-130,244
| -49% | -$2.7M | 0.01% | 1176 |
|
|
2020
Q2 | $6.79M | Sell |
267,243
-56,225
| -17% | -$1.21M | 0.03% | 523 |
|
|
2020
Q1 | $5.94M | Sell |
323,468
-234,139
| -42% | -$4.55M | 0.05% | 432 |
|
|
2019
Q4 | $12.3M | Buy |
+557,607
| New | +$11.2M | 0.04% | 535 |
|
|
2019
Q3 | – | Sell |
-52,379
| Closed | -$825K | – | 3917 |
|
|
2019
Q2 | $825K | Buy |
+52,379
| New | +$712K | ﹤0.01% | 2096 |
|
|
2019
Q1 | – | Sell |
-116,152
| Closed | -$1.24M | – | 3596 |
|
|
2018
Q4 | $1.24M | Buy |
116,152
+34,433
| +42% | +$453K | ﹤0.01% | 1507 |
|
|
2018
Q3 | $1.25M | Sell |
81,719
-19,312
| -19% | -$281K | ﹤0.01% | 1818 |
|
|
2018
Q2 | $1.24M | Buy |
101,031
+38,254
| +61% | +$481K | ﹤0.01% | 1991 |
|
|
2018
Q1 | $600K | Buy |
+62,777
| New | +$677K | ﹤0.01% | 2367 |
|
|
2016
Q3 | – | Sell |
-30,134
| Closed | -$90K | – | 3464 |
|
|
2016
Q2 | $90K | Buy |
+30,134
| New | +$124K | ﹤0.01% | 2831 |
|
Other funds holding DRNA
Two Sigma Investments's DRNA Position: Q4 2021 in Review
Two Sigma Investments sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 575,111 shares — an estimated $11.6M sold.
Two Sigma Investments first reported a position in DRNA in Q2 2016 and held it in 13 quarters. The position peaked at $12.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Two Sigma Investments reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Two Sigma Investments sold 575,111 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $11.6M.
- Two Sigma Investments first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2016 and held it in 13 quarters.
- Two Sigma Investments's Dicerna Pharmaceuticals, Inc. position peaked at $12.3M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Two Sigma Investments's 13F filing for Q4 2021, filed 14 Feb 2022.